Real-time estimation of patient-specific dose distributions for medical CT using the deep dose estimation

Descriptive overview of AI applications in x-ray imaging and radiotherapy

Artificial intelligence (AI) is transforming medical radiation applications by handling complex data, learning patterns, and making accurate predictions, leading to improved patient outcomes. This article examines the use of AI in optimising radiation doses for x-ray imaging, improving radiotherapy outcomes, and briefly addresses the benefits, challenges, and limitations of AI integration into clinical workflows. In diagnostic radiology, AI plays a pivotal role in optimising radiation exposure, reducing noise, enhancing image contrast, and lowering radiation doses, especially in high-dose procedures like computed tomography (CT). Deep learning (DL)-powered CT reconstruction methods have already been incorporated into clinical routine. Moreover, AI-powered methodologies have been developed to provide real-time, patient-specific radiation dose estimates. These AI-driven tools have the potential to streamline workflows and potentially become integral parts of imaging practices. In radiotherapy, AI's ability to automate and enhance the precision of treatment planning is emphasised. Traditional methods, such as manual contouring, are time-consuming and prone to variability. AI-driven techniques, particularly DL models, are automating the segmentation of organs and tumours, improving the accuracy of radiation delivery, and minimising damage to healthy tissues. Moreover, AI supports adaptive radiotherapy, allowing continuous optimisation of treatment plans based on changes in a patient's anatomy over time, ensuring the highest accuracy in radiation delivery and better therapeutic outcomes. Some of these methods have been validated and integrated into radiation treatment systems, while others are not yet ready for routine clinical use mainly due to challenges in validation, particularly ensuring reliability across diverse patient populations and clinical settings. Despite the potential of AI, there are challenges in fully integrating these technologies into clinical practice. Issues such as data protection, privacy, data quality, model validation, and the need for large and diverse datasets are crucial to ensuring the reliability of AI systems.

[Artificial intelligence in diagnostic radiology for dose management : Advances and perspectives using the example of computed tomography]

CLINICAL-METHODOLOGICAL PROBLEM

Imaging procedures employing ionizing radiation require compliance with European directives and national regulations in order to protect patients. Each exposure must be indicated, individually adapted, and documented. Unacceptable dose exceedances must be detected and reported. These tasks are time-consuming and require meticulous diligence.

STANDARD RADIOLOGICAL METHODS

Computed tomography (CT) is the most important contributor to medical radiation exposure. Optimizing the patient's dose is therefore mandatory. Use of modern technology and reconstruction algorithms already reduces exposure. Checking the indication, planning, and performing the examination are further important process steps with regard to radiation protection. Patient exposure is usually monitored by dose management systems (DMS). In special cases, a risk assessment is required by calculating the organ doses.

METHODOLOGICAL INNOVATIONS

Artificial intelligence (AI)-assisted techniques are increasingly used in various steps of the process: they support examination planning, improve patient positioning, and enable automated scan length adjustments. They also provide real-time estimates of individual organ doses.

EVALUATION

The integration of AI into medical imaging is proving successful in terms of dose optimization in various areas of the radiological workflow, from reconstruction to examination planning and performing exams. However, the use of AI in conjunction with DMS has not yet been considered on a large scale.

PRACTICAL RECOMMENDATION

AI processes offer promising tools to support dose management. However, their implementation in the clinical setting requires further research, extensive validation, and continuous monitoring.

Patient radiation risk reduction by controlling the tube start angle in single and dual source spiral CT scans: A simulation study

BACKGROUND

Organ doses in spiral CT scans depend on the tube start angle.

PURPOSE

To determine the effective dose in single source CT (SSCT) and dual source CT (DSCT) scans as a function of tube start angle and spiral pitch value to identify the dose reduction potential by selecting the optimal start angle.

METHODS

Using Monte Carlo simulations, dose values for different tube positions with an angular increment of10 ∘ $10^\circ$ and a longitudinal increment of4.5 m m $4.5 \,\mathrm{m}\mathrm{m}$ were simulated over a range of31.5 c m $31.5 \,\mathrm{c}\mathrm{m}$ with collimations of40 mm $40\, \mathrm{mm}$ ,60 mm $60\, \mathrm{mm}$ , and80 m m $80 \,\mathrm{m}\mathrm{m}$ . The simulations were performed for the thorax region of six adult patients based on clinical CT data. From the resulting dose distributions, organ doses and effective dose were determined as a function of tube angle and longitudinal position. Using these per-view dose data, the individual organ doses, as well as the total effective dose, were determined for spiral scans with and without tube current modulation (TCM) with pitch values ranging from 0.5 to 1.5 for SSCT and up to 3.0 for DSCT. The dose of the best and worst tube start angle in terms of dose was determined and compared to the mean dose over all tube start angles.

RESULTS

With increasing pitch and collimation, the dose variations from the effective dose averaged over all start angles increase. While for a collimation of40 m m $40 \,\mathrm{m}\mathrm{m}$ , the variations from the mean dose value stay below5 % $5 \%$ for SSCT, we find that for a spiral scan with a pitch of 3.0 for DSCT with TCM and collimation of80 m m $80 \,\mathrm{m}\mathrm{m}$ , the dose for the best starting angle is on average16 % $16 \%$ lower than the mean value and28 % $28 \%$ lower than the maximum value.

CONCLUSIONS

Variation of the tube start angle in spiral scans exhibits substantial differences in radiation dose especially for high pitch values and for high collimations. Therefore, we suggest to control the tube start angle to minimize patient risk.

An inventory of patient-image based risk/dose, image quality and body habitus/size metrics for adult abdomino-pelvic CT protocol optimisation

PURPOSE

Patient-specific protocol optimisation in abdomino-pelvic Computed Tomography (CT) requires measurement of body habitus/size (BH), sensitivity-specificity (surrogates image quality (IQ) metrics) and risk (surrogates often dose quantities) (RD). This work provides an updated inventory of metrics available for each of these three categories of optimisation variables derivable directly from patient measurements or images. We consider objective IQ metrics mostly in the spatial domain (i.e., those related directly to sharpness, contrast, noise quantity/texture and perceived detectability as these are used by radiologists to assess the acceptability or otherwise of patient images in practice).

MATERIALS AND METHODS

The search engine used was PubMed with the search period being 2010-2024. The key words used were: 'comput* tomography', 'CT', 'abdom*', 'dose', 'risk', 'SSDE', 'image quality', 'water equivalent diameter', 'size', 'body composition', 'habit*', 'BMI', 'obes*', 'overweight'. Since BH is critical for patient specific optimisation, articles correlating RD vs BH, and IQ vs BH were reviewed.

RESULTS

The inventory includes 11 BH, 12 IQ and 6 RD metrics. 25 RD vs BH correlation studies and 9 IQ vs BH correlation studies were identified. 7 articles in the latter group correlated metrics from all three categories concurrently.

CONCLUSIONS

Protocol optimisation should be fine-tuned to the level of the individual patient and particular clinical query. This would require a judicious choice of metrics from each of the three categories. It is suggested that, for increased utility in clinical practice, more future optimisation studies be clinical task based and involve the three categories of metrics concurrently.

Fast prediction of personalized abdominal organ doses from CT examinations by radiomics feature-based machine learning models

The X-rays emitted during CT scans can increase solid cancer risks by damaging DNA, with the risk tied to patient-specific organ doses. This study aims to establish a new method to predict patient specific abdominal organ doses from CT examinations using minimized computational resources at a fast speed. The CT data of 247 abdominal patients were selected and exported to the auto-segmentation software named DeepViewer to generate abdominal regions of interest (ROIs). Radiomics feature were extracted based on the selected CT data and ROIs. Reference organ doses were obtained by GPU-based Monte Carlo simulations. The support vector regression (SVR) model was trained based on the radiomics features and reference organ doses to predict abdominal organ doses from CT examinations. The prediction performance of the SVR model was tested and verified by changing the abdominal patients of the train and test sets randomly. For the abdominal organs, the maximal difference between the reference and the predicted dose was less than 1 mGy. For the body and bowel, the organ doses were predicted with a percentage error of less than 5.2%, and the coefficient of determination (R2) reached up to 0.9. For the left kidney, right kidney, liver, and spinal cord, the mean absolute percentage error ranged from 5.1 to 8.9%, and the R2 values were more than 0.74. The SVR model could be trained to achieve accurate prediction of personalized abdominal organ doses in less than one second using a single CPU core.

Introducing fitting models for estimating age-specific dose and effective dose in paediatric patients undergoing head, chest and abdomen-pelvis imaging protocols: a patient study

INTRODUCTION

Concerns regarding the adverse consequences of radiation have increased due to the expanded application of computed tomography (CT) in medical practice. Certain studies have indicated that the radiation dosage depends on the anatomical region, the imaging technique employed and patient-specific variables. The aim of this study is to present fitting models for the estimation of age-specific dose estimates (ASDE), in the same direction of size-specific dose estimates, and effective doses based on patient age, gender and the type of CT examination used in paediatric head, chest and abdomen-pelvis imaging.

METHODS

A total of 583 paediatric patients were included in the study. Radiometric data were gathered from DICOM files. The patients were categorised into five distinct groups (under 15 years of age), and the effective dose, organ dose and ASDE were computed for the CT examinations involving the head, chest and abdomen-pelvis. Finally, the best fitting models were presented for estimation of ASDE and effective doses based on patient age, gender and the type of examination.

RESULTS

The ASDE in head, chest, and abdomen-pelvis CT examinations increases with increasing age. As age increases, the effective dose in head and abdomen-pelvis CT scans decreased. However, for chest scans, the effective dose initially showed a decreasing trend until the first year of life; after that, it increases in correlation with age.

CONCLUSIONS

Based on the presented fitting model for the ASDE, these CT scan quantities depend on factors such as patient age and the type of CT examination. For the effective dose, the gender was also included in the fitting model. By utilising the information about the scan type, region and age, it becomes feasible to estimate the ASDE and effective dose using the models provided in this study.

Fully automated explainable abdominal CT contrast media phase classification using organ segmentation and machine learning

BACKGROUND

Contrast-enhanced computed tomography (CECT) provides much more information compared to non-enhanced CT images, especially for the differentiation of malignancies, such as liver carcinomas. Contrast media injection phase information is usually missing on public datasets and not standardized in the clinic even in the same region and language. This is a barrier to effective use of available CECT images in clinical research.

PURPOSE

The aim of this study is to detect contrast media injection phase from CT images by means of organ segmentation and machine learning algorithms.

METHODS

A total number of 2509 CT images split into four subsets of non-contrast (class #0), arterial (class #1), venous (class #2), and delayed (class #3) after contrast media injection were collected from two CT scanners. Seven organs including the liver, spleen, heart, kidneys, lungs, urinary bladder, and aorta along with body contour masks were generated by pre-trained deep learning algorithms. Subsequently, five first-order statistical features including average, standard deviation, 10, 50, and 90 percentiles extracted from the above-mentioned masks were fed to machine learning models after feature selection and reduction to classify the CT images in one of four above mentioned classes. A 10-fold data split strategy was followed. The performance of our methodology was evaluated in terms of classification accuracy metrics.

RESULTS

The best performance was achieved by Boruta feature selection and RF model with average area under the curve of more than 0.999 and accuracy of 0.9936 averaged over four classes and 10 folds. Boruta feature selection selected all predictor features. The lowest classification was observed for class #2 (0.9888), which is already an excellent result. In the 10-fold strategy, only 33 cases from 2509 cases (∼1.4%) were misclassified. The performance over all folds was consistent.

CONCLUSIONS

We developed a fast, accurate, reliable, and explainable methodology to classify contrast media phases which may be useful in data curation and annotation in big online datasets or local datasets with non-standard or no series description. Our model containing two steps of deep learning and machine learning may help to exploit available datasets more effectively.

Is deep learning-enabled real-time personalized CT dosimetry feasible using only patient images as input?

PURPOSE

To propose a novel deep-learning based dosimetry method that allows quick and accurate estimation of organ doses for individual patients, using only their computed tomography (CT) images as input.

METHODS

Despite recent advances in medical dosimetry, personalized CT dosimetry remains a labour-intensive process. Current state-of-the-art methods utilize time-consuming Monte Carlo (MC) based simulations for individual organ dose estimation in CT. The proposed method uses conditional generative adversarial networks (cGANs) to substitute MC simulations with fast dose image generation, based on image-to-image translation. The pix2pix architecture in conjunction with a regression model was utilized for the generation of the synthetic dose images. The lungs, heart, breast, bone and skin were manually segmented to estimate and compare organ doses calculated using both the original and synthetic dose images, respectively.

RESULTS

The average organ dose estimation error for the proposed method was 8.3% and did not exceed 20% for any of the organs considered. The performance of the method in the clinical environment was also assessed. Using segmentation tools developed in-house, an automatic organ dose calculation pipeline was set up. Calculation of organ doses for heart and lung for each CT slice took about 2 s.

CONCLUSIONS

This work shows that deep learning-enabled personalized CT dosimetry is feasible in real-time, using only patient CT images as input.

Implementation of a new EGSnrc particle source class for computed tomography: validation and uncertainty quantification

Objective. Personalized dose monitoring and risk management are of increasing significance with the growing number of computer tomography (CT) examinations. These require high-quality Monte Carlo (MC) simulations that are of the utmost importance for the new developments in personalized CT dosimetry. This work aims to extend the MC framework EGSnrc source code with a new particle source. This, in turn, allows CT-scanner-specific dose and image calculations for any CT scanner. The novel method can be used with all modern EGSnrc user codes, particularly for the simulation of the effective dose based on DICOM images and the calculation of CT images.Approach. The new particle source can be used with input data derived by the user. The input data can be generated by the user based on a previously developed method for the experimental characterization of any CT scanner (doi.org/10.1016/j.ejmp.2015.09.006). Furthermore, the new particle source was benchmarked by air kerma measurements in an ionization chamber at a clinical CT scanner. For this, the simulated angular distribution and attenuation characteristics were compared to measurements to verify the source output free in air. In a second validation step, simulations of air kerma in a homogenous cylindrical and an anthropomorphic thorax phantom were performed and validated against experimentally determined results. A detailed uncertainty evaluation of the simulated air kerma values was developed.Main results. We successfully implemented a new particle source class for the simulation of realistic CT scans. This method can be adapted to any CT scanner. For the attenuation characteristics, there was a maximal deviation of 6.86% between the measurement and the simulation. The mean deviation for all tube voltages was 2.36% (σ= 1.6%). For the phantom measurements and simulations, all the values agreed within 5.0%. The uncertainty evaluation resulted in an uncertainty of 5.5% (k=1).

Two-view topogram-based anatomy-guided CT reconstruction for prospective risk minimization

To facilitate a prospective estimation of the effective dose of an CT scan prior to the actual scanning in order to use sophisticated patient risk minimizing methods, a prospective spatial dose estimation and the known anatomical structures are required. To this end, a CT reconstruction method is required to reconstruct CT volumes from as few projections as possible, i.e. by using the topograms, with anatomical structures as correct as possible. In this work, an optimized CT reconstruction model based on a generative adversarial network (GAN) is proposed. The GAN is trained to reconstruct 3D volumes from an anterior-posterior and a lateral CT projection. To enhance anatomical structures, a pre-trained organ segmentation network and the 3D perceptual loss are applied during the training phase, so that the model can then generate both organ-enhanced CT volume and organ segmentation masks. The proposed method can reconstruct CT volumes with PSNR of 26.49, RMSE of 196.17, and SSIM of 0.64, compared to 26.21, 201.55 and 0.63 using the baseline method. In terms of the anatomical structure, the proposed method effectively enhances the organ shapes and boundaries and allows for a straight-forward identification of the relevant anatomical structures. We note that conventional reconstruction metrics fail to indicate the enhancement of anatomical structures. In addition to such metrics, the evaluation is expanded with assessing the organ segmentation performance. The average organ dice of the proposed method is 0.71 compared with 0.63 for the baseline model, indicating the enhancement of anatomical structures.

Predicting patient-specific organ doses from thoracic CT examinations using support vector regression algorithm

PURPOSE

This study aims to propose and develop a fast, accurate, and robust prediction method of patient-specific organ doses from CT examinations using minimized computational resources.

MATERIALS AND METHODS

We randomly selected the image data of 723 patients who underwent thoracic CT examinations. We performed auto-segmentation based on the selected data to generate the regions of interest (ROIs) of thoracic organs using the DeepViewer software. For each patient, radiomics features of the thoracic ROIs were extracted via the Pyradiomics package. The support vector regression (SVR) model was trained based on the radiomics features and reference organ dose obtained by Monte Carlo (MC) simulation. The root mean squared error (RMSE), mean absolute percentage error (MAPE), and coefficient of determination (R-squared) were evaluated. The robustness was verified by randomly assigning patients to the train and test sets of data and comparing regression metrics of different patient assignments.

RESULTS

For the right lung, left lung, lungs, esophagus, heart, and trachea, results showed that the trained SVR model achieved the RMSEs of 2 mGy to 2.8 mGy on the test sets, 1.5 mGy to 2.5 mGy on the train sets. The calculated MAPE ranged from 0.1 to 0.18 on the test sets, and 0.08 to 0.15 on the train sets. The calculated R-squared was 0.75 to 0.89 on test sets.

CONCLUSIONS

By combined utilization of the SVR algorithm and thoracic radiomics features, patient-specific thoracic organ doses could be predicted accurately, fast, and robustly in one second even using one single CPU core.

A fully automated machine learning-based methodology for personalized radiation dose assessment in thoracic and abdomen CT

PURPOSE

To develop a machine learning-based methodology for patient-specific radiation dosimetry in thoracic and abdomen CT.

METHODS

Three hundred and thirty-one thoracoabdominal radiotherapy-planning CT examinations with the respective organ/patient contours were collected retrospectively for the development and validation of segmentation 3D-UNets. Moreover, 97 diagnostic thoracic and 89 diagnostic abdomen CT examinations were collected retrospectively. For each of the diagnostic CT examinations, personalized MC dosimetry was performed. The data derived from MC simulations along with the respective CT data were used for the training and validation of a dose prediction deep neural network (DNN). An algorithm was developed to utilize the trained models and perform patient-specific organ dose estimates for thoracic and abdomen CT examinations. The doses estimated with the DNN were compared with the respective doses derived from MC simulations. A paired t-test was conducted between the DNN and MC results. Furthermore, the time efficiency of the proposed methodology was assessed.

RESULTS

The mean percentage differences (range) between DNN and MC dose estimates for the lungs, liver, spleen, stomach, and kidneys were 7.2 % (0.2-24.1 %), 5.5 % (0.4-23.0 %), 7.9 % (0.6-22.3 %), 6.9 % (0.0-23.0 %) and 6.7 % (0.3-22.6 %) respectively. The differences between DNN and MC dose estimates were not significant (p-value = 0.12). Moreover, the mean processing time of the proposed workflow was 99 % lower than the respective time needed for MC-based dosimetry.

CONCLUSIONS

The proposed methodology can be used for rapid and accurate patient-specific dosimetry in chest and abdomen CT.

Real-time, acquisition parameter-free voxel-wise patient-specific Monte Carlo dose reconstruction in whole-body CT scanning using deep neural networks

OBJECTIVE

We propose a deep learning-guided approach to generate voxel-based absorbed dose maps from whole-body CT acquisitions.

METHODS

The voxel-wise dose maps corresponding to each source position/angle were calculated using Monte Carlo (MC) simulations considering patient- and scanner-specific characteristics (SP_MC). The dose distribution in a uniform cylinder was computed through MC calculations (SP_uniform). The density map and SP_uniform dose maps were fed into a residual deep neural network (DNN) to predict SP_MC through an image regression task. The whole-body dose maps reconstructed by the DNN and MC were compared in the 11 test cases scanned with two tube voltages through transfer learning with/without tube current modulation (TCM). The voxel-wise and organ-wise dose evaluations, such as mean error (ME, mGy), mean absolute error (MAE, mGy), relative error (RE, %), and relative absolute error (RAE, %), were performed.

RESULTS

The model performance for the 120 kVp and TCM test set in terms of ME, MAE, RE, and RAE voxel-wise parameters was  - 0.0302 ± 0.0244 mGy, 0.0854 ± 0.0279 mGy,  - 1.13 ± 1.41%, and 7.17 ± 0.44%, respectively. The organ-wise errors for 120 kVp and TCM scenario averaged over all segmented organs in terms of ME, MAE, RE, and RAE were  - 0.144 ± 0.342 mGy, and 0.23 ± 0.28 mGy,  - 1.11 ± 2.90%, 2.34 ± 2.03%, respectively.

CONCLUSION

Our proposed deep learning model is able to generate voxel-level dose maps from a whole-body CT scan with reasonable accuracy suitable for organ-level absorbed dose estimation.

CLINICAL RELEVANCE STATEMENT

We proposed a novel method for voxel dose map calculation using deep neural networks. This work is clinically relevant since accurate dose calculation for patients can be carried out within acceptable computational time compared to lengthy Monte Carlo calculations.

KEY POINTS

• We proposed a deep neural network approach as an alternative to Monte Carlo dose calculation. • Our proposed deep learning model is able to generate voxel-level dose maps from a whole-body CT scan with reasonable accuracy, suitable for organ-level dose estimation. • By generating a dose distribution from a single source position, our model can generate accurate and personalized dose maps for a wide range of acquisition parameters.

Rapid estimation of patient-specific organ doses using a deep learning network

BACKGROUND

Patient-specific organ-dose estimation in diagnostic CT examinations can provide useful insights on individualized secondary cancer risks, protocol optimization, and patient management. Current dose estimation techniques mainly rely on time-consuming Monte Carlo methods or/and generalized anthropomorphic phantoms.

PURPOSE

We proposed a proof-of-concept rapid workflow based on deep learning networks to estimate organ doses for individuals following thorax Computed Tomography (CT) examinations.

METHODS

CT scan data from 95 individuals undergoing thorax CT examinations were used. Monte Carlo simulations were performed and three-dimensional (3D) dose distributions for each patient were obtained. A fully connected sequential deep learning network model was constructed and trained for each organ considered in this study. Water-equivalent diameter (WED), scan length, and tube current were the independent variables. Organ doses for heart, lungs, esophagus, and bones were calculated from the Monte Carlo 3D distribution and used to train the deep learning networks. Organ dose predictions from each network were evaluated using an independent data set of 19 patients.

RESULTS

The trained networks provided organ dose predictions within a second. There was very good agreement between the deep learning network predictions and reference organ dose values calculated from Monte Carlo simulations. The average difference was -1.5% for heart, -1.6% for esophagus, -1.0% for lungs, and -0.4% for bones in the 95 patients dataset, and -5.1%, 4.3%, 0.9%, and 1.4% respectively in the 19 patients test dataset.

CONCLUSIONS

The proposed workflow demonstrated that patient-specific organ-doses can be estimated in nearly real-time using deep learning networks. The workflow can be readily implemented and requires a small set of representative data for training.

Towards real-time EPID-based 3D in vivo dosimetry for IMRT with Deep Neural Networks: A feasibility study

We investigate the potential of the Deep Dose Estimate (DDE) neural network to predict 3D dose distributions inside patients with Monte Carlo (MC) accuracy, based on transmitted EPID signals and patient CTs. The network was trained using as input patient CTs and first-order dose approximations (FOD). Accurate dose distributions (ADD) simulated with MC were given as training targets. 83 pelvic CTs were used to simulate ADDs and respective EPID signals for subfields of prostate IMRT plans (gantry at 0∘). FODs were produced as backprojections from the EPID signals. 581 ADD-FOD sets were produced and divided into training and test sets. An additional dataset simulated with gantry at 90∘ (lateral set) was used for evaluating the performance of the DDE at different beam directions. The quality of the FODs and DDE-predicted dose distributions (DDEP) with respect to ADDs, from the test and lateral sets, was evaluated with gamma analysis (3%,2 mm). The passing rates between FODs and ADDs were as low as 46%, while for DDEPs the passing rates were above 97% for the test set. Meaningful improvements were also observed for the lateral set. The high passing rates for DDEPs indicate that the DDE is able to convert FODs into ADDs. Moreover, the trained DDE predicts the dose inside a patient CT within 0.6 s/subfield (GPU), in contrast to 14 h needed for MC (CPU-cluster). 3D in vivo dose distributions due to clinical patient irradiation can be obtained within seconds, with MC-like accuracy, potentially paving the way towards real-time EPID-based in vivo dosimetry.

Computed Tomography 2.0: New Detector Technology, AI, and Other Developments

ABSTRACT

Computed tomography (CT) dramatically improved the capabilities of diagnostic and interventional radiology. Starting in the early 1970s, this imaging modality is still evolving, although tremendous improvements in scan speed, volume coverage, spatial and soft tissue resolution, as well as dose reduction have been achieved. Tube current modulation, automated exposure control, anatomy-based tube voltage (kV) selection, advanced x-ray beam filtration, and iterative image reconstruction techniques improved image quality and decreased radiation exposure. Cardiac imaging triggered the demand for high temporal resolution, volume acquisition, and high pitch modes with electrocardiogram synchronization. Plaque imaging in cardiac CT as well as lung and bone imaging demand for high spatial resolution. Today, we see a transition of photon-counting detectors from experimental and research prototype setups into commercially available systems integrated in patient care. Moreover, with respect to CT technology and CT image formation, artificial intelligence is increasingly used in patient positioning, protocol adjustment, and image reconstruction, but also in image preprocessing or postprocessing. The aim of this article is to give an overview of the technical specifications of up-to-date available whole-body and dedicated CT systems, as well as hardware and software innovations for CT systems in the near future.

Fast dose calculation in x-ray guided interventions by using deep learning

Objective.Patient dose estimation in x-ray-guided interventions is essential to prevent radiation-induced biological side effects. Current dose monitoring systems estimate the skin dose based in dose metrics such as the reference air kerma. However, these approximations do not take into account the exact patient morphology and organs composition. Furthermore, accurate organ dose estimation has not been proposed for these procedures. Monte Carlo simulation can accurately estimate the dose by recreating the irradiation process generated during the x-ray imaging, but at a high computation time, limiting an intra-operative application. This work presents a fast deep convolutional neural network trained with MC simulations for patient dose estimation during x-ray-guided interventions.Approach.We introduced a modified 3D U-Net that utilizes a patient's CT scan and the numerical values of imaging settings as input to produce a Monte Carlo dose map. To create a dataset of dose maps, we simulated the x-ray irradiation process for the abdominal region using a publicly available dataset of 82 patient CT scans. The simulation involved varying the angulation, position, and tube voltage of the x-ray source for each scan. We additionally conducted a clinical study during endovascular abdominal aortic repairs to validate the reliability of our Monte Carlo simulation dose maps. Dose measurements were taken at four specific anatomical points on the skin and compared to the corresponding simulated doses. The proposed network was trained using a 4-fold cross-validation approach with 65 patients, and evaluating the performance on the remaining 17 patients during testing.Main results.The clinical validation demonstrated a average error within the anatomical points of 5.1%. The network yielded test errors of 11.5 ± 4.6% and 6.2 ± 1.5% for peak and average skin doses, respectively. Furthermore, the mean errors for the abdominal region and pancreas doses were 5.0 ± 1.4% and 13.1 ± 2.7%, respectively.Significance.Our network can accurately predict a personalized 3D dose map considering the current imaging settings. A short computation time was achieved, making our approach a potential solution for dose monitoring and reporting commercial systems.

[Risk-minimizing tube current modulation for computed tomography]

AIM/PROBLEM

Every computed tomography (CT) examination is accompanied by radiation exposure. The aim is to reduce this as much as possible without compromising image quality by using a tube current modulation technique.

STANDARD PROCEDURE

CT tube current modulation (TCM), which has been in use for about two decades, adjusts the tube current to the patient's attenuation (in the angular and z‑directions) in a way that minimizes the mAs product (tube current-time product) of the scan without compromising image quality. This mAsTCM, present in all CT devices, is associated with a significant dose reduction in those anatomical areas that have high attenuation differences between anterior-posterior (a.p.) and lateral, particularly the shoulder and pelvis. Radiation risk of individual organs or of the patient is not considered in mAsTCM.

METHODOLOGICAL INNOVATION

Recently, a TCM method was proposed that directly minimizes the patient's radiation risk by predicting organ dose levels and taking them into account when choosing tube current. It is shown that this so-called riskTCM is significantly superior to mAsTCM in all body regions. To be able to use riskTCM in clinical routine, only a software adaptation of the CT system would be necessary.

CONCLUSIONS

With riskTCM, significant dose reductions can be achieved compared to the standard procedure, typically around 10%-30%. This is especially true in those body regions where the standard procedure shows only moderate advantages over a scan without any tube current modulation at all. It is now up to the CT vendors to take action and implement riskTCM.

A nonparametric measure of noise in x-ray diagnostic images-mammography

Objective.In x-ray diagnostics, modern image reconstruction or image processing methods may render established methods of image quality assessment inadequate. Task specific quality assessment by using model observers has the disadvantage of being very labour-intensive. Therefore, it appears highly desirable to develop novel image quality parameters that neither rely on the linearity and the shift-invariace of the imaging system nor require the acquisition of hundreds of images as is necessary for the application of model observers, and which can be derived directly from diagnostic images.Approach.A new measure for the noise based on non-maximum-suppression images is defined and its properties are explored using simulated images before it is applied to an exposure series of mammograms of a homogeneous phantom and a 3D-printed breast phantom to demonstrate its usefulness under realistic conditions.Main results.The new noise parameter cannot only be derived from images with a homogeneous background but it can be extracted directly from images containing anatomic structures and is proportional to the standard deviation of the noise. At present, the applicability is restricted to mammography, which satisfies the assumption of short covariance length of the noise.Significance.The new measure of the noise is but a first step of the development of a set of parameters that are required to quantify image quality directly from diagnostic images without relying on the assumption of a linear, shift-invariant system, e.g. by providing measures of sharpness, contrast and structural complexity, in addition to the noise measure. For mammography, a convenient method is now available to quantify noise in processed diagnostic images.

Fully automated accurate patient positioning in computed tomography using anterior-posterior localizer images and a deep neural network: a dual-center study

OBJECTIVES

This study aimed to improve patient positioning accuracy by relying on a CT localizer and a deep neural network to optimize image quality and radiation dose.

METHODS

We included 5754 chest CT axial and anterior-posterior (AP) images from two different centers, C1 and C2. After pre-processing, images were split into training (80%) and test (20%) datasets. A deep neural network was trained to generate 3D axial images from the AP localizer. The geometric centerlines of patient bodies were indicated by creating a bounding box on the predicted images. The distance between the body centerline, estimated by the deep learning model and ground truth (BCAP), was compared with patient mis-centering during manual positioning (BCMP). We evaluated the performance of our model in terms of distance between the lung centerline estimated by the deep learning model and the ground truth (LCAP).

RESULTS

The error in terms of BCAP was - 0.75 ± 7.73 mm and 2.06 ± 10.61 mm for C1 and C2, respectively. This error was significantly lower than BCMP, which achieved an error of 9.35 ± 14.94 and 13.98 ± 14.5 mm for C1 and C2, respectively. The absolute BCAP was 5.7 ± 5.26 and 8.26 ± 6.96 mm for C1 and C2, respectively. The LCAP metric was 1.56 ± 10.8 and -0.27 ± 16.29 mm for C1 and C2, respectively. The error in terms of BCAP and LCAP was higher for larger patients (p value < 0.01).

CONCLUSION

The accuracy of the proposed method was comparable to available alternative methods, carrying the advantage of being free from errors related to objects blocking the camera visibility.

KEY POINTS

• Patient mis-centering in the anterior-posterior direction (AP) is a common problem in clinical practice which can degrade image quality and increase patient radiation dose. • We proposed a deep neural network for automatic patient positioning using only the CT image localizer, achieving a performance comparable to alternative techniques, such as the external 3D visual camera. • The advantage of the proposed method is that it is free from errors related to objects blocking the camera visibility and that it could be implemented on imaging consoles as a patient positioning support tool.

Patient-specific radiation risk-based tube current modulation for diagnostic CT

PURPOSE

Modern CT scanners use automatic exposure control (AEC) techniques, such as tube current modulation (TCM), to reduce dose delivered to patients while maintaining image quality. In contrast to conventional approaches that minimize the tube current time product of the CT scan, referred to as mAsTCM in the following, we herein propose a new method referred to as riskTCM which aims at reducing the radiation risk to the patient by taking into account the specific radiation risk of every dose-sensitive organ.

METHODS

For current mAsTCM implementations, the mAs-product is used as a surrogate for the patient dose. Thus they do not take into account the varying dose sensitivity of different organs. Our riskTCM framework assumes that a coarse CT reconstruction, an organ segmentation and an estimation of the dose distribution can be provided in real time, e.g. by applying machine learning techniques. Using this information riskTCM determines a tube current curve that minimizes a patient risk measure, e.g. the effective dose, while keeping the image quality constant. We retrospectively applied riskTCM to 20 patients covering all relevant anatomical regions and tube voltages from 70 kV to 150 kV. The potential reduction of effective dose at same image noise is evaluated as a figure of merit and compared to mAsTCM and to a situation with a constant tube current referred to as noTCM.

RESULTS

Anatomical regions like the neck, thorax, abdomen and the pelvis benefit from the proposed riskTCM. On average, a reduction of effective dose of about 23 % for the thorax, 31 % for the abdomen, 24 % for the pelvis, and 27% for the neck have been evaluated compared to today's state-of-the-art mAsTCM. For the head, the resulting reduction of effective dose is lower, about 13 % on average compared to mAsTCM.

CONCLUSIONS

With a risk-minimizing tube current modulation, significant higher reduction of effective dose compared to mAs-minimizing tube current modulation is possible. This article is protected by copyright. All rights reserved.